Acta obstetricia et gynecologica Scandinavica · 2009
Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.
СтатьяПоддержка исследования: вне правительства СШАВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Petri Anette Lykke, Kjaer Susanne Krüger, Christensen Ib J, Blaakaer Jan, Hogdall Estrid, Jeppesen Ulla, Mosgaard Berit J, Pagel Jens D, Stilling Line, Thranov Ingrid, Hogdall Claus
Аннотация
OBJECTIVE: To validate the data on epithelial ovarian cancer, fallopian tube cancer and borderline ovarian tumors registered in the nationwide Danish Gynecological Cancer Database (DGCD) in 2005 and 2006. The DGCD is a multidisciplinary database that contains data for research and quality improvement.
DESIGN: Comparative registry-based study supplemented with data from medical records.
SETTING: Six hospitals in Denmark.
PARTICIPANTS: Women registered with epithelial ovarian cancer, fallopian tube cancer and borderline ovarian tumor.
MAIN OUTCOME MEASURE: Data completeness and strength of agreement.
RESULTS: The estimated completeness of reporting to the DGCD was 94.2% and the strength of agreement between the variables in the DGCD and the medical file varied from moderate to very good. The important quality indicator 'complication' had the lowest strength of agreement.
CONCLUSION: The validity of ovarian cancer data in the DGCD is sufficient for quality monitoring in gynecological oncology.
DESIGN: Comparative registry-based study supplemented with data from medical records.
SETTING: Six hospitals in Denmark.
PARTICIPANTS: Women registered with epithelial ovarian cancer, fallopian tube cancer and borderline ovarian tumor.
MAIN OUTCOME MEASURE: Data completeness and strength of agreement.
RESULTS: The estimated completeness of reporting to the DGCD was 94.2% and the strength of agreement between the variables in the DGCD and the medical file varied from moderate to very good. The important quality indicator 'complication' had the lowest strength of agreement.
CONCLUSION: The validity of ovarian cancer data in the DGCD is sufficient for quality monitoring in gynecological oncology.